Clinical Trials Directory

Trials / Completed

CompletedNCT00737048

A Comparative Study of JNS013 in Participants With Post-Tooth-Extraction Pain

A Double-Blind Comparative Study of JNS013 in Patients With Post-Tooth-Extraction Pain

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
328 (actual)
Sponsor
Janssen Pharmaceutical K.K. · Industry
Sex
All
Age
20 Years – 74 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the efficacy and safety of JNS013 with single oral dose administration in participants with pain after tooth-extraction of mandibular impacted wisdom tooth.

Detailed description

This is a multi-center (conducted in more than one center), double-blind (neither Physician nor participant knows the name of the assigned drug), randomized (study drug assigned by chance), parallel-group (each group of participant will be treated at the same time) and comparative study in participants having pain intensity of at least 50.0 millimeter (mm) (on visual analog scale, score ranging from 0 mm \[no pain\] to 100 mm \[worst possible pain\]), following extraction of an impacted mandibular wisdom tooth. The study consists of 3 parts: Pre-observation (7 days before study commences on Day 1); Treatment (Day 1, consists of single oral dosing of either tramadol plus acetaminophen and placebo; or tramadol and placebo; or acetaminophen and placebo) and Follow-up (Day 2 and 8). All the eligible participants will be randomly assigned to 1 of the 3 study treatments. Efficacy of the participants will primarily be evaluated through total pain relief, which will be evaluated on numerical rating scale. Participants' safety will be monitored throughout the study.

Conditions

Interventions

TypeNameDescription
DRUGTramadol HydrochlorideTramadol hydrochloride two oral capsules will be administered once as 75 milligram (mg).
DRUGAcetaminophenAcetaminophen two oral capsules will be administered once as 650 mg.
DRUGPlaceboTwo oral tablets or capsules of matching Placebo will be administered once along with Tramadol Hydrochloride and/or acetaminophen.
DRUGTramadol plus AcetaminophenTramadol hydrochloride and acetaminophen combination tablet will be administered as single oral dosing of two tablets at a dose of 75 and 650 milligram respectively.

Timeline

Start date
2008-03-01
Primary completion
2008-09-01
Completion
2008-09-01
First posted
2008-08-18
Last updated
2016-03-31
Results posted
2013-08-01

Locations

11 sites across 1 country: Japan

Source: ClinicalTrials.gov record NCT00737048. Inclusion in this directory is not an endorsement.